Clinical trials
Overweight or Obese clinical trials
Below are recruiting overweight or obese clinical trials, each written for real people, not researchers. We’re tracking 1,472 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07091500Recruiting
Exercise and a weight-loss drug for people with obesity
This trial tests whether combining a GLP-1 medication (a type of diabetes drug that also helps with weight loss) with an exercise program can improve physical function in people with obesity. If you are obese and have trouble with daily activities, this study may help you become more mobile and healthier.
St Louis, MissouriAges 50–75 - NCT07083557Recruiting
Validation study for lab tests on hormones and metabolism
This study checks if lab tests used for hormone, heart, metabolism, and muscle disorders are accurate and reliable. You might be eligible if you are an adult with a body mass index between 16 and 60.
Columbia, MissouriAges 18–100 - NCT06983431Recruiting
Digital health program for weight management
This study uses a smartphone app and a wearable device to help you manage your weight and health risks. It is for people with a body mass index (BMI) between 27 and 42 who are ready to make healthy changes.
Bratislava, Bratislava RegionAges 25–65 - NCT07065552RecruitingEarly Phase 1
Tirzepatide for weight-linked endometrial cancer
This trial tests if the weight-loss drug tirzepatide can help people with obesity-related endometrial cancer before their hysterectomy. It may improve surgical outcomes and overall health.
Chapel Hill, North CarolinaAges 18 years+ - NCT07073781Recruiting
Probiotics for Brain & Blood Sugar in Overweight Young Adults
This study tests whether taking a probiotic (a 'good bacteria' supplement) can help brain function (thinking, memory) and improve blood sugar control in overweight adults who have higher-than-normal blood sugar. If you're between 18-40, overweight, and don't have diabetes, you may be able to join.
Leeds, Greater ManchesterAges 18–40 - NCT07057453Recruiting
National childhood obesity prevention program for kids
This program helps children ages 6–11 who are overweight (but not obese) learn healthy habits to prevent obesity. It focuses on lifestyle changes and does not involve any medication or surgery.
Prague, CzechiaAges 6–11 - NCT07062315Enrolling by invitation
Eating at the right time for belly fat reduction
This study tests a type of intermittent fasting where you eat only during a certain window that matches your body clock. The goal is to see if this helps reduce belly fat and improve metabolic health in people who are not very active and carry extra weight around the middle.
Hong KongAges 18–65 - NCT07058155RecruitingPhase 4
TIPS and weight-loss surgery for liver disease with high blood pressure
This trial tests if doing a TIPS procedure (to lower blood pressure in the liver) before weight-loss surgery (sleeve gastrectomy) helps people with advanced liver disease. It's for those who have cirrhosis and very high blood pressure in the liver, and who qualify for sleeve gastrectomy.
Cleveland, OhioAges 18–70 - NCT07057310Enrolling by invitationPhase 4
Weight Loss Drug for Postmenopausal Women With Obesity
This study tests a GLP-1 agonist medication (like Ozempic) to help postmenopausal women lose weight and improve physical and blood vessel health. It focuses on women aged 46–60 with obesity.
Jacksonville, FloridaAges 46–60 - NCT07058207Recruiting
Weight management program for obese cancer patients in treatment
This study offers a weight management program for people with obesity who are undergoing active cancer treatment (chemo or radiation) for a solid tumor. It aims to help you manage your weight while you fight cancer, and requires living in the Barcelona area.
L'Hospitalet de Llobregat, BarcelonaAges 18 years+ - NCT06987279Recruiting
Probiotics for hormone balance in overweight women
This trial tests whether a specific probiotic, Lactobacillus plantarum, can help regulate hormones in overweight women. It involves taking daily probiotic capsules and providing samples over a period of time.
Zhengzhou, HenanAges 18–40 - NCT07052539Recruiting
Kidney disease in heart failure with obesity
This study looks at how kidney disease relates to a type of heart failure (called HFpEF) that often happens in people with obesity. It will help doctors understand this connection better.
Jackson, MississippiAges 18–75 - NCT07036172RecruitingPhase 3
Semaglutide vs Wegovy for weight loss in Chinese adults
This trial compares a semaglutide injection to the already-approved weight loss drug Wegovy in Chinese adults with obesity. It aims to see if the new option works just as well to help people lose weight.
BeijingAges 18–75 - NCT07037459RecruitingPhase 3
A study of a new drug for heart failure with obesity
This trial tests a medication called maridebart cafraglutide for people with heart failure (where the heart doesn't pump as well as it should) and obesity. The goal is to see if it can help improve symptoms and outcomes.
Birmingham, AlabamaAges 18–99 - NCT07038252Recruiting
Oral supplement effect on blood vessel health in obesity and hypertension
This trial tests whether an oral supplement made from special fats (called Specialized Pro-resolving Mediators) can help reduce blood vessel damage caused by inflammation in people with obesity and high blood pressure. If you have well-controlled high blood pressure and are obese, you may be able to join.
ParisAges 18–85 - NCT06742710RecruitingPhase 4
Liraglutide for obese infertility in PCOS
This trial tests if liraglutide, a weight-loss medication, can help obese women with PCOS who have a frozen embryo achieve pregnancy. It aims to improve fertility outcomes by aiding weight loss before embryo transfer.
Beijing, Beijing MunicipalityAges 20–40 - NCT07027033Recruiting
Oleic acid's effect on cholesterol metabolism in women with obesity
This study tests whether a special type of fatty acid (oleic acid) can change how the body handles cholesterol in women with obesity who are having weight-loss surgery. It will help researchers understand if this nutrient can improve cholesterol metabolism and reduce insulin resistance.
Nantes, FranceAges 18–60 - NCT07033221Recruiting
Balance and inner ear function in obesity
This study looks at how obesity affects your sense of balance (vestibular function). It compares people with obesity who are candidates for weight-loss surgery to people without obesity, to see if weight affects balance.
Istanbul, KüçükçekmeceAges 18–60 - NCT07031297Recruiting
Exosome release after a meal in obesity
This study looks at how the body releases tiny particles called exosomes from the upper arm after a meal, specifically in women with obesity. It helps researchers understand how fat tissue responds to eating.
Rochester, MinnesotaAges 18–55 - NCT07020741Recruiting
Stable isotope study in adults with obesity
This study uses a special test (stable isotopes) to learn about how adults with obesity process food and energy. It may help researchers understand weight and metabolism better.
Urbana, IllinoisAges 19–59 - NCT07012967Recruiting
Taping for breathing and sleep in obesity
This study tests whether kinesio taping improves breathing and sleep quality in people who are overweight or have class 1 or 2 obesity. You will wear a special tape on your body to see if it helps you breathe better and sleep well.
IstanbulAges 18–70 - NCT07011628Recruiting
Transition to outpatient weight-loss surgery trial
This study tests if sending you home the same day after weight-loss surgery is safe and effective. You must have a BMI of 60 or less and be getting your first sleeve gastrectomy or gastric bypass at Vanderbilt University Medical Center.
Nashville, TennesseeAges 25–55 - NCT06994650RecruitingPhase 3
Study of HRS9531 for sleep apnea and obesity
This trial tests an injection called HRS9531 to see if it helps people with obstructive sleep apnea (OSA) and obesity who already use a CPAP or similar breathing device. It may help by reducing weight and improving breathing during sleep.
Beijing, Beijing MunicipalityAges 18–75 - NCT07001865Enrolling by invitation
Effects of healthy obesity on liver and uric acid risks
This study looks at people who are metabolically healthy but overweight or obese, and how that affects their risk of developing fatty liver disease (MASLD) or high uric acid levels (hyperuricemia). It aims to see if 'healthy' obesity still carries hidden health risks.
NingboAges 18–100
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for overweight or obese?
- Yes. Clin2 currently lists 1,472 recruiting overweight or obese studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a overweight or obese trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a overweight or obese trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.